Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson vs adenosine for stress echocardiography in coronary artery disease diagnosis
CTR20231854Phase 3Completed
- Sponsor
- Recbio
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of regadenoson in coronary arteriosclerosis, sponsored by Recbio. Started Jun 2023; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on CTR20231854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231854.